Cancer
Experts Urge Reevaluation of Hormone Replacement Therapy Post-Breast Cancer
A groundbreaking synthesis of research and expert insights has recently emerged, shedding new light on the contentious issue of hormone...
Treatment Patterns and Survival in Metastatic ACC
In the complex landscape of metastatic adenoid cystic carcinoma (ACC) of the head and neck, researchers face a significant challenge:...
LncRNA LOXL1-AS1 Boosts Ovarian Cancer via BRIP1
In the relentless quest to unravel the molecular intricacies of ovarian cancer, a recent study spearheaded by Wan, Su, Ding,...
Cardiovascular Disease Influences Colorectal Cancer Outcomes
In a groundbreaking study published in BMC Cancer, researchers have unveiled compelling evidence highlighting the significant influence of cardiovascular disease...
Lenvatinib with Radiotherapy vs. Chemoembolization in Liver Cancer
In a groundbreaking comparative study poised to reshape the therapeutic landscape for advanced hepatocellular carcinoma (HCC), researchers have unveiled compelling...
Using ATR-FTIR Spectroscopy to Differentiate Metaplastic Breast Carcinoma, Ductal Carcinoma In Situ, and Invasive Ductal Carcinoma
In a groundbreaking advance for cancer diagnostics, researchers have harnessed the power of Attenuated Total Reflectance Fourier-Transform Infrared (ATR-FTIR) spectroscopy...
Organoid Models Mirror Ovarian Cancer Platinum Response
In the relentless battle against ovarian cancer—the deadliest among gynecological malignancies—a novel avenue of research is providing renewed hope and...
New Advances in Liver Cancer Therapy: Targeting Glypican-3 for Improved Treatment
Glypican-3 (GPC3) has emerged as one of the most promising targets in the fight against hepatocellular carcinoma (HCC), a highly...
Combining Radiomics and Deep Learning CT Signatures of Liver and Spleen Enhances Hepatocellular Carcinoma Risk Prediction in Cirrhosis Patients
In the relentless battle against hepatocellular carcinoma (HCC), a formidable consequence of cirrhosis, the need for precise and individualized risk...
Adverse Events of Lutetium-177-PSMA-617 Revealed
Lutetium-177-PSMA-617 (Pluvicto®) has emerged as a groundbreaking radiolabeled therapeutic agent in the battle against advanced prostate cancer, specifically targeting metastatic...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!